Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib

被引：26

作者：

Luo, Jing ^{[1
]}

Gu, Dejian ^{[2
]}

Lu, Huasong ^{[1
]}

Liu, Si ^{[1
]}

Kong, Jinliang ^{[1
]}

机构：

[1] Guangxi Med Univ, Affiliated Hosp 1, Pulm & Crit Care Med Ward, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China

[2] Geneplus Beijing Ltd, Beijing, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 12期

关键词：

VARIANT;

D O I：

10.1016/j.jtho.2019.07.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E266 / E268

页数：4

共 5 条

[1]

Clark AS, 2003, CANCER RES, V63, P780

[2] SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing [J].

Hou, Xue ;

Xu, Huamin ;

Chen, Likun .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) :E72-E73

[3] A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib [J].

Lin, Hao ;

Ren, Guoqiang ;

Liang, Xiaohua .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) :E234-E236

[4] Identification of a Novel EML4-ALK, BCL11A-ALK Double-Fusion Variant in Lung Adenocarcinoma Using Next-Generation Sequencing and Response to Crizotinib [J].

Qin, Bao-Dong ;

Jiao, Xiao-Dong ;

Liu, Ke ;

Wu, Ying ;

Zang, Yuan-Sheng .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) :E115-E117

[5] Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib [J].

Yin, Jinping ;

Zhang, Yu ;

Zhang, Yan ;

Peng, Feng ;

Lu, You .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) :E43-E45

← 1 →